Safely Prescribing Nirmatrelvir and Ritonavir - Avoiding Drug-Drug Interactions

Roshni Culas; Sridesh Nath; Sarath Nath

doi:10.1001/jamainternmed.2022.6834

Safely Prescribing Nirmatrelvir and Ritonavir - Avoiding Drug-Drug Interactions

Roshni Culas
, Sridesh Nath
, Sarath Nath

Infectious Diseases

Memorial Sloan-Kettering Cancer Center
University of Pittsburgh

Research output: Contribution to journal › Review article › peer-review

13 Scopus citations

Original language	English
Pages (from-to)	362-363
Number of pages	2
Journal	JAMA Internal Medicine
Volume	183
Issue number	4
DOIs	https://doi.org/10.1001/jamainternmed.2022.6834
State	Published - Apr 3 2023

Access to Document

10.1001/jamainternmed.2022.6834

Cite this

@article{065caa69e3bf498cb23d75f85889152f,

title = "Safely Prescribing Nirmatrelvir and Ritonavir - Avoiding Drug-Drug Interactions",

author = "Roshni Culas and Sridesh Nath and Sarath Nath",

year = "2023",

month = apr,

day = "3",

doi = "10.1001/jamainternmed.2022.6834",

language = "English",

volume = "183",

pages = "362--363",

journal = "JAMA Internal Medicine",

issn = "2168-6106",

number = "4",

}

TY - JOUR

T1 - Safely Prescribing Nirmatrelvir and Ritonavir - Avoiding Drug-Drug Interactions

AU - Culas, Roshni

AU - Nath, Sridesh

AU - Nath, Sarath

PY - 2023/4/3

Y1 - 2023/4/3

UR - https://www.scopus.com/pages/publications/85152157521

U2 - 10.1001/jamainternmed.2022.6834

DO - 10.1001/jamainternmed.2022.6834

M3 - Review article

C2 - 36807493

AN - SCOPUS:85152157521

SN - 2168-6106

VL - 183

SP - 362

EP - 363

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

IS - 4

ER -

Safely Prescribing Nirmatrelvir and Ritonavir - Avoiding Drug-Drug Interactions

Access to Document

Other files and links

Fingerprint

Cite this